Login / Signup

In-vivo and in-silico studies revealed the molecular mechanisms of Colocasia esculenta phenolics as novel chemotherapy against benign prostatic hyperplasia via inhibition of 5α-reductase and α1-adrenoceptor.

Deusdedit TusubiraJonasi MunezeroPeter Chinedu AguClement Olusoji AjayiJoseph OloroNathiim NamaleFrank SsedyabaneCaroline Kiwanuka NakiguliAbayomi E AdegboyegaPatrick Maduabuchi Aja
Published in: In silico pharmacology (2023)
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • molecular docking
  • locally advanced
  • case control
  • single cell
  • squamous cell carcinoma
  • chemotherapy induced
  • rectal cancer
  • molecular dynamics simulations